Death receptor 6

"DR6" redirects here. For the highway in the Dominican Republic, see DR-6. For the debug register, see DR6 register.
Tumor necrosis factor receptor superfamily, member 21

PDB rendering based on 2dbh.
Available structures
PDB Ortholog search: PDBe, RCSB
Identifiers
Symbols TNFRSF21 ; BM-018; CD358; DR6
External IDs OMIM: 605732 MGI: 2151075 HomoloGene: 8696 GeneCards: TNFRSF21 Gene
RNA expression pattern
More reference expression data
Orthologs
Species Human Mouse
Entrez 27242 94185
Ensembl ENSG00000146072 ENSMUSG00000023915
UniProt O75509 Q9EPU5
RefSeq (mRNA) NM_014452 NM_178589
RefSeq (protein) NP_055267 NP_848704
Location (UCSC) Chr 6:
47.23 – 47.31 Mb
Chr 17:
43.02 – 43.09 Mb
PubMed search

Death receptor 6 (DR6), also known as tumor necrosis factor receptor superfamily member 21 (TNFRSF21), is a cell surface receptor of the tumor necrosis factor receptor superfamily which activates the JNK and NF-κB pathways.[1][2] It is mostly expressed in the thymus, spleen and white blood cells.[3]

Function

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor has been shown to activate NF-κB and MAPK8/JNK, and induce cell apoptosis. Through its death domain, this receptor interacts with TRADD protein, which is known to serve as an adaptor that mediates signal transduction of TNF-receptors. Knockout studies in mice suggested that this gene plays a role in T helper cell activation, and may be involved in inflammation and immune regulation.[2]

Clinical significance

DR6 is also thought to be involved in neurodegeneration in the brain that causes Alzheimer's disease as well as signal transduction in stress response and cellular survival.[4] DR6 induces apoptosis when it is over expressed, however the manner in which the death signal is intracellularly transduced is currently unknown. It has been determined that Bax translocation is necessary for the apoptosis triggered by DR6, but through an unknown pathway instead of the traditional pathways of intrinsic versus extrinsic.[5] APP (amyloid precursor protein) is the natural ligand of DR6 and is first cleaved into and N-APP. N-APP is the fragment that interacts with DR6 to trigger axonal degradation in Alzheimer's patients.[6] This pathway is essentially "hi-jacked" in the aging brain.

References

  1. Pan G, Bauer JH, Haridas V, Wang S, Liu D, Yu G, Vincenz C, Aggarwal BB, Ni J, Dixit VM (July 1998). "Identification and functional characterization of DR6, a novel death domain-containing TNF receptor". FEBS Lett. 431 (3): 351–356. doi:10.1016/S0014-5793(98)00791-1. PMID 9714541.
  2. 1 2 "Entrez Gene: TNFRSF21 tumor necrosis factor receptor superfamily, member 21".
  3. Salido, Ginés María; Rosado, Juan Antonio (2009). Apoptosis: Involvement of Oxidative Stress and Intracellular Ca2+ Homeostasis. Heidelberg, Germany: Springer. p. 37.
  4. Kuester M, Kemmerzehl S, Dahms SO, Roeser D, Than ME (June 2011). "The crystal structure of death receptor 6 (DR6): a potential receptor of the amyloid precursor protein (APP)". J. Mol. Biol. 409 (2): 189–201. doi:10.1016/j.jmb.2011.03.048. PMID 21463639.
  5. Cetin F (2012). "Role of oxidative stress in Aβ animal model of Alzheimer’s disease: Vicious circle of apoptosis, nitric oxide and age". INTECH.
  6. Osherovich L (2009). "Genentech's new parADigm". Science-Business eXchange 2 (8): 1–5. doi:10.1038/scibx.2009.300.

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

This article is issued from Wikipedia - version of the Sunday, July 26, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.